BioSpace News Archive

Policy

Government Files Criminal Charges Against Opioid Distributor and Two Former Executives

The government said the executives and the company failed to comply with its legal obligation to report thousands of suspicious orders of controlled substances to the DEA.

April 24, 2019
·
3 min read
·
Alex Keown
Genetown

Fulcrum Therapeutics Licenses Failed GSK Drug for Possible Muscular Dystrophy Indication

Cambridge, Mass.-based Fulcrum Therapeutics just acquired a worldwide license with GlaxoSmithKline (GSK) to develop and commercialize losmapimod.

April 24, 2019
·
2 min read
·
Mark Terry
Business

BioSpace’s Global Biopharma Roundup: April 25

Companies across Europe and Asia provide information about deal, clinical trials and more, with news from Synaptive Medical, Epic, Inventiva, Velabs, and more.

April 24, 2019
·
4 min read
·
Alex Keown
Business

Academic entrepreneur Brian Bellhouse celebrated with naming of new building

Turf cutting for the Bellhouse Building to be performed by Lord & Lady Drayson

April 24, 2019
·
3 min read
Business

Ellume Appoints CFO And CBO

Ellume Limited is pleased to announce the appointment of David Green as Chief Financial Officer and Company Secretary, and Mark Boyle Chief Business Officer of the Company.

April 24, 2019
·
2 min read
Cytura Therapeutics to Develop a New Class of Drugs Targeting genomic instability in cancer

Cytura Therapeutics announces the successful closure of a Seed financing round.

April 24, 2019
·
3 min read
Biotech Beach

Arcutis, Inc. Founded to Address Gap in Immuno-Dermatology Drug Development

Arcutis, Inc., a privately held immuno-dermatology drug development company, was formed in 2016 to address significant unmet needs in dermatology.

April 24, 2019
·
4 min read
Pharm Country

Despite a Q1 Drop in Sales, J&J Anticipates New Indications Will Increase Xarelto Revenue Growth

Life sciences giant blamed the Medicare “doughnut hole” and increased competition for the blood thinner’s declining sales.

April 24, 2019
·
2 min read
·
Alex Keown
Eisai Selected as Competitive ICT Strategy Company for 2019

Recognized for Taking on Challenge of Transformation to New Business Models by Integrating Management and Ict Strategies

April 24, 2019
·
2 min read
Deals

MDxHealth (R): MDxHealth provides Q1 2019 business update

MDxHealth SA, a commercial-stage innovative molecular diagnostics company, provided a business update for the first quarter ended March 31, 2019.

April 24, 2019
·
4 min read